Organization · Venture Capital
Israel Biotech Fund
Israel Biotech Fund is a venture capital firm based in Rehovot, Israel, specializing in investments in Israeli and Israeli-related biotechnology companies focused on drug development. The fund aims to support clinical-stage companies with strong scientific and commercial prospects.
Overview
What Israel Biotech Fund does
What Israel Biotech Fund is
Israel Biotech Fund is a venture capital firm based in Rehovot, Israel, specializing in investments in Israeli and Israeli-related biotechnology companies focused on drug development. The fund aims to support clinical-stage companies with strong scientific and commercial prospects.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Israel Biotech Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Israel Biotech Fund as a funder
Investment thesis
Israel Biotech Fund invests in Israeli and Israeli-related biotechnology and pharmaceutical companies where drug-development opportunities are supported by strong science and commercial potential.
Focus narrative
Israel Biotech Fund invests exclusively in Israeli and Israeli-related biotechnology and pharmaceutical companies that possess exceptional technologies or product opportunities grounded in strong scientific rationale and commercial potential. The fund provides portfolio companies with resources for sustainable growth, including access to networks, executive talent, and business development resources.
Value beyond capital
The fund emphasizes therapeutic assets rather than broad healthcare services, using scientific diligence, industry networks, and venture advisors to help portfolio companies develop assets, access executive talent, pursue strategic and operational resources, and build long-term value.
Focus and fit
- Stages
- Seed · Growth Equity
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: 4C Biomed: A biotechnology company focused on developing innovative therapies. Aion Labs: A company dedicated to advancing biotech innovations. Ayala Pharmaceuticals: Engaged in developing targeted therapies for cancer. Biond Biologics: Focused on developing novel immunotherapies. Gamida Cell: Specializes in cell therapy for cancer and other serious diseases. MediWound: Develops and commercializes innovative therapies for tissue repair and regeneration. Nectin Therapeutics: Focuses on developing therapies for cancer treatment. Pharma2B: A company involved in the development of pharmaceutical products. Vensica: Works on innovative drug delivery systems.
Common questions
What to know about Israel Biotech Fund
Upseed classifies Israel Biotech Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.